Eli Lilly & Co.

NYSE: LLY
$153.86
+$1.41 (+0.9%)
Closing price June 2, 2020
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be acquiring the firm.
Chris Lange
The top analyst upgrades, downgrades and initiations for the final trading days of 2019 included Activision Blizzard, Amazon.com, Apple, Boeing, Eli Lilly, Johnson & Johnson, Lennar, Nio, Nvidia...
Jon C. Ogg
The December 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released treatments for...
Paul Ausick
Wednesday's top analyst upgrades, downgrades and initiations included Activision Blizzard, Datadog, Delta Air Lines, Eli Lilly, FedEx, Halliburton, Kinder Morgan, Skechers, Teladoc and Waste...
Jon C. Ogg
The November 29 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Chris Lange
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Chris Lange
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Chris Lange
Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.
Chris Lange
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Jon C. Ogg
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Jon C. Ogg
The September 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Chris Lange
Eli Lilly announced some good news for people suffering moderate to severe plaque psoriasis when it presented at the 5th Annual Maui Derm NP+PA Fall meeting.
Chris Lange